Patents by Inventor Patrick Wire

Patrick Wire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
    Publication number: 20240041846
    Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, compositions thereof, and methods of using them are provided.
    Type: Application
    Filed: October 12, 2023
    Publication date: February 8, 2024
    Inventors: Darrell BAKER, Mark BRUCE, Glenn CRATER, Brian NOGA, Marian THOMAS, Patrick WIRE
  • COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
    Publication number: 20220047565
    Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.
    Type: Application
    Filed: October 29, 2021
    Publication date: February 17, 2022
    Inventors: Darrell BAKER, Mark BRUCE, Glenn CRATER, Brian NOGA, Marian THOMAS, Patrick WIRE
  • Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
    Patent number: 11090294
    Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: August 17, 2021
    Assignee: Glaxo Group Limited
    Inventors: Darrell Baker, Mark Bruce, Glenn Crater, Brian Noga, Marian Thomas, Patrick Wire
  • COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
    Publication number: 20200171009
    Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.
    Type: Application
    Filed: February 4, 2020
    Publication date: June 4, 2020
    Applicant: Glaxo Group Limited
    Inventors: Darrell BAKER, Mark BRUCE, Glenn CRATER, Brian NOGA, Marian THOMAS, Patrick WIRE
  • COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
    Publication number: 20180008582
    Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.
    Type: Application
    Filed: August 16, 2017
    Publication date: January 11, 2018
    Inventors: Darrell BAKER, Mark Bruce, Glenn Crater, Brian Noga, Marian Thomas, Patrick Wire
  • Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
    Patent number: 9750726
    Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: September 5, 2017
    Assignee: Glaxo Group Limited
    Inventors: Darrell Baker, Mark Bruce, Glenn Crater, Brian Noga, Marian Thomas, Patrick Wire
  • COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
    Publication number: 20160095840
    Abstract: Combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.
    Type: Application
    Filed: December 16, 2015
    Publication date: April 7, 2016
    Inventors: Darrell BAKER, Mark BRUCE, Glenn CRATER, Brian NOGA, Marian THOMAS, Patrick WIRE
  • COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
    Publication number: 20120309725
    Abstract: Novel combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided.
    Type: Application
    Filed: November 29, 2010
    Publication date: December 6, 2012
    Inventors: Darrell Baker, Mark Bruce, Glenn Crater, Brian Noga, Marian Thomas, Patrick Wire